.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Daiichi Sankyo
Johnson and Johnson
Healthtrust
Julphar
Farmers Insurance
Argus Health
McKinsey
Harvard Business School
Novartis

Generated: June 28, 2017

DrugPatentWatch Database Preview

MITOXANTRONE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Mitoxantrone Hydrochloride, and when can generic versions of Mitoxantrone Hydrochloride launch?

Mitoxantrone Hydrochloride is a drug marketed by Fresenius Kabi Oncol, West-ward Pharms Int, Mylan Labs Ltd, Teva Pharms Usa, Hospira, Mylan Institutional, and Fresenius Kabi Usa. and is included in seven NDAs.

The generic ingredient in MITOXANTRONE HYDROCHLORIDE is mitoxantrone hydrochloride. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the mitoxantrone hydrochloride profile page.

Summary for Tradename: MITOXANTRONE HYDROCHLORIDE

Patents:0
Applicants:7
NDAs:7
Suppliers / Packagers: see list4
Bulk Api Vendors: see list57
Clinical Trials: see list2,471
Patent Applications: see list5,367
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MITOXANTRONE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: MITOXANTRONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Oncol
MITOXANTRONE HYDROCHLORIDE
mitoxantrone hydrochloride
INJECTABLE;INJECTION078606-001May 14, 2008DISCNNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
MITOXANTRONE HYDROCHLORIDE
mitoxantrone hydrochloride
INJECTABLE;INJECTION077496-003Apr 11, 2006APRXNoNo► Subscribe► Subscribe
Mylan Labs Ltd
MITOXANTRONE HYDROCHLORIDE
mitoxantrone hydrochloride
INJECTABLE;INJECTION201014-001Dec 11, 2012APRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
MITOXANTRONE HYDROCHLORIDE
mitoxantrone hydrochloride
INJECTABLE;INJECTION076611-001Apr 11, 2006APRXNoNo► Subscribe► Subscribe
Hospira
MITOXANTRONE HYDROCHLORIDE
mitoxantrone hydrochloride
INJECTABLE;INJECTION076871-002Apr 11, 2006APRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
AstraZeneca
US Department of Justice
Cipla
Fuji
Colorcon
Teva
Queensland Health
Julphar
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot